Skip to content
Screener

Harvard Bioscience HBIO Q4 2025 Annual earnings

Reported March 12, 2026 · Before market open

Revenue$23.7MBeat by $635.0K
EPS-$0.01Miss by $0.36
Revenue estimate$23.1M
EPS estimate$0.35

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$21.8M
EPS estimate-$0.17

FAQ

When did Harvard Bioscience report Q4 2025 earnings?
Harvard Bioscience (HBIO) reported Q4 2025 earnings on March 12, 2026 before market open.
What were Harvard Bioscience's Q4 2025 revenue and EPS?
Harvard Bioscience reported revenue of $23.7M and eps of $-0.01 for Q4 2025.
Did Harvard Bioscience beat estimates in Q4 2025?
Revenue beat the consensus estimate of $23.1M by $635.0K. EPS missed the consensus estimate of $0.35 by $0.36.
How did Harvard Bioscience's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.3% from $24.6M a year earlier.
Where can I find Harvard Bioscience's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001171843-26-001447) and the 10-K periodic report (0001171843-26-001548) directly on SEC EDGAR. The filing index links above go to sec.gov.